![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Global | Publication | January 2019
M&A activity in the energy sector will be driven in part by the transition to lower carbon energy sources as investors seek to future-proof their businesses or satisfy environmental, social and governance requirements. Growing activity is expected in the renewable heating and transport fuel sectors, as these sectors become the focus of policy interventions.
Norton Rose Fulbright advised ABN Amro, BP, Gunvor, ING, Koch Supply & Trading, Mercuria, Shell, Société Générale and Equinor in a corporate joint venture for the purpose of developing a commodities trading platform using distributed ledger technology. By managing physical energy transactions on a distributed ledger, the joint venture (now known at Vakt) aims to create a secure, trusted ecosystem for counterparty interaction, with anticipated gains in cybersecurity, operational efficiency and trade finance.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023